Lattice Semiconductor Free cash flow decreased by 9.7% to $39.72M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 70.7%, from $23.28M to $39.72M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows a downward trend with a -4.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $28.10M | $38.19M | $42.65M | $48.94M | $38.78M | $45.22M | $59.74M | $71.72M | $36.45M | $67.07M | $77.73M | $68.24M | $26.09M | $14.78M | $39.36M | $39.67M | $23.28M | $31.30M | $34.03M | $43.98M | $39.72M |
| QoQ Change | — | +35.9% | +11.7% | +14.7% | -20.8% | +16.6% | +32.1% | +20.1% | -49.2% | +84.0% | +15.9% | -12.2% | -61.8% | -43.4% | +166.4% | +0.8% | -41.3% | +34.5% | +8.7% | +29.2% | -9.7% |
| YoY Change | — | — | — | — | +38.0% | +18.4% | +40.1% | +46.5% | -6.0% | +48.3% | +30.1% | -4.9% | -28.4% | -78.0% | -49.4% | -41.9% | -10.8% | +111.8% | -13.6% | +10.9% | +70.7% |